Cardiac stem cells in the real world.

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Stem Cell Biology

Background:

• Cardiac stem cell transplantation is a promising strategy for myocardial regeneration after infarction.
• Clinical relevance of endogenous cardiac precursors remains unclear, with most data from animal studies.

Purpose of the Study:

• To investigate the presence and characteristics of cardiac stem cells in human heart tissue.
• To evaluate the potential of these cells for therapeutic applications in ischemic cardiomyopathy.

Main Methods:

• Prospective screening of endomyocardial biopsies from heart transplant recipients and right appendage biopsies.
• Immunohistochemical detection of stemness markers (c-kit, MDR-1, Isl-1), hematopoietic (CD45), mast cell (tryptase), endothelial (CD105), and cardiac lineage (Nkx2.5) markers.
• Confocal microscopy for colocalization and flow cytometry for cell sorting.

Main Results:

• Low numbers of c-kit-positive cells were found in both biopsy types, significantly fewer in right appendage samples.
• All c-kit-positive cells co-stained for CD45 and tryptase, identifying them as mast cells.
• No c-kit-positive cells expressed stemness markers MDR-1 and Isl-1 or cardiac lineage markers.

Conclusions:

• Human cardiac c-kit-positive cells are predominantly mast cells, not stem cells.
• These findings caution against the therapeutic use of cardiac stem cells for ischemic cardiomyopathy regeneration.
• Further research is needed to identify true cardiac stem cell populations for regenerative therapies.